Healthlynked Corp (HLYK)

Healthlynked Corp has recorded no insider trading activity within the past ninety days. The most recent transactions occurred in June 2024, when Chief Financial Officer David Rosal executed two separate purchases of company shares. Prior to these events, historical filings indicate additional acquisitions by various executives dating back to early 2021.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: HLYK Exchange: OTC

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Healthlynked Corp

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

0.9

Rosal David Chief Financial Officer Officer

Transaction date 24 Jun 2024

Purchase

Price

19.87

Quantity 67,428 +13.6%

Value US$909,537

0.9

Rosal David Chief Financial Officer Officer

Transaction date 20 Jun 2024

Purchase

Price

205.57

Quantity 45,527 -28.4%

Value US$2,509,795

Mino Robert P. Non-Executive Director

Transaction date 2 Mar 2021

Purchase

Price

48.96

Quantity 15,051 -38.2%

Value US$821,068

Comments Filing

O'Leary George Chief Financial Officer Executive Director

Transaction date 1 Mar 2021

Purchase

Price

0.50

Quantity 50,000 +1.3%

Value US$25,000

Comments Filing

O'Leary George Chief Financial Officer Executive Director

Transaction date 13 Jan 2021

Purchase

Price

0.00

Quantity 100,000

Value US$0

Comments Filing

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-06-24	2024-06-24	B Purchase	0.9 Rosal David Chief Financial Officer Officer	67,428 +13.6% 19.87 US$909,537	67,428 +13.6%	19.87	US$909,537
2024-06-24	2024-06-20	B Purchase	0.9 Rosal David Chief Financial Officer Officer	45,527 -28.4% 205.57 US$2,509,795	45,527 -28.4%	205.57	US$2,509,795
2021-03-03	2021-03-02	B Purchase	Mino Robert P. Non-Executive Director	15,051 -38.2% 48.96 US$821,068	15,051 -38.2%	48.96	US$821,068
2021-03-03	2021-03-01	B Purchase	O'Leary George Chief Financial Officer Executive Director	50,000 +1.3% 0.50 US$25,000	50,000 +1.3%	0.50	US$25,000
2021-01-14	2021-01-13	B Purchase	O'Leary George Chief Financial Officer Executive Director	100,000 0.00 US$0	100,000	0.00	US$0